Recent Endemic Coronavirus Infection Associates With Higher SARS-CoV-2 Cross-Reactive Fc Receptor Binding Antibodies

David J Bean,Yan Mei Liang,Manish Sagar

DOI: https://doi.org/10.1101/2024.10.23.619886

2024-10-23

Abstract:Recent documented infection with an endemic coronavirus (eCoV) associates with less severe coronavirus disease 2019 (COVID-19), yet the immune mechanism behind this protection has not been fully explored. We measured both antibody and T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in SARS-CoV-2 naive individuals classified into two groups, either with or without presumed recent eCoV infections. There was no difference in neutralizing antibodies and T cell responses against SARS-CoV-2 antigens between the two groups. SARS-CoV-2 naive individuals with recent presumed eCoV infection, however, had higher levels of Fc receptor (FcR) binding antibodies against eCoV spikes (S) and SARS-CoV-2 S2. There was also a significant correlation between eCoV and SARS-CoV-2 FcR binding antibodies. Recent eCoV infection boosts cross-reactive antibodies that can mediate Fc effector functions, and this may play a role in the observed heterotypic immune protection against severe COVID-19.

Immunology

What problem does this paper attempt to address?

### Problems the paper attempts to solve

This paper aims to explore whether recent infection with endemic coronaviruses (eCoV) can enhance the cross - reactive antibody response to severe acute respiratory syndrome coronavirus 2 (SARS - CoV - 2), especially whether these antibodies can mediate a protective effect through Fc receptor - binding function, thereby reducing the severity of COVID - 19.

### Specific research background and problems

1. **Background**:
- Humans are infected with endemic coronaviruses (such as HCoV - 229E, HCoV - HKU1, HCoV - NL63 and HCoV - OC43) every 18 months to 2 years.
- It is hypothesized that the cross - reactive immune response generated by infection with one coronavirus may have a protective effect on the infection or disease severity of another heterologous coronavirus.
- A large retrospective cohort study showed that individuals with a recent record of endemic coronavirus infection had a lower severity of COVID - 19 after infection with SARS - CoV - 2, but there was no difference in the incidence of SARS - CoV - 2.

2. **Unresolved problems**:
- Although this protective effect has been observed, the underlying immune mechanisms have not been fully elucidated.
- Some studies have found that pre - existing humoral and cellular immunity may reduce the infection rate of SARS - CoV - 2 and the severity of COVID - 19, but the results of these studies are not consistent.
- Few studies have directly explored the changes in cross - reactive immune responses after recent endemic coronavirus infection.

### Research methods

- **Classification methods**:
- Use PCR detection and endemic coronavirus nucleocapsid antibody titer data to classify individuals who may have been recently infected with endemic coronaviruses.
- Compare the cross - reactive immune responses to SARS - CoV - 2 antigens between these individuals and those not infected with endemic coronaviruses.

- **Main indicators**:
- Measure IgG antibody levels, neutralizing antibody activity, and levels of Fc receptor (FcR) - binding antibodies.
- Pay special attention to the levels of Fc γRIIIa - binding antibodies to the SARS - CoV - 2 spike protein (S2 region).

### Main findings

- **Antibody response**:
- In individuals recently infected with endemic coronaviruses, the levels of SARS - CoV - 2 S2 - specific Fc γRIIIa - binding antibodies were significantly increased.
- These antibodies were positively correlated with endemic coronavirus spike protein - specific Fc γRIIIa - binding antibodies.

- **T - cell response**:
- Recent endemic coronavirus infection did not significantly enhance the T - cell response against SARS - CoV - 2 antigens.

### Conclusions

- **Role of Fc receptor - binding antibodies**:
- Recent endemic coronavirus infection enhanced the levels of SARS - CoV - 2 S2 - specific Fc γRIIIa - binding antibodies, which may mediate the protection against severe COVID - 19 through Fc effector functions (such as ADCC and ADCP).
- This finding provides a new perspective for understanding how endemic coronavirus infection affects the SARS - CoV - 2 immune response and is helpful for the development of broad - spectrum coronavirus vaccines.

### Future directions

- **Further verification**:
- More research is needed to verify this finding and explore the roles of other Fc receptors in it.
- Understand the specific functions of these antibodies (such as ADCC, ADCP and ADE) and their roles in the pathology of COVID - 19.

Through these studies, scientists can better understand the cross - protection mechanisms between different coronaviruses and provide important clues for future vaccine design.